Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma

Indian Journal of Cancer

Volumn 48, Issue 4, 2011, Pages 513-514

  Basu, S ^a   Tiwari, B P ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18;

BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; LETTER; ORCHIECTOMY; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROSTATE CARCINOMA;

CARCINOMA; EARLY DETECTION OF CANCER; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS;

EID: 84856841461     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.92247     Document Type: Letter

References (6)

1. Tiwari BP, Jangra S, Nair N, Tongaonkar HB, Basu S. Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma. Indian J Cancer 2010;47:385-90.
2. Basu S, Torigian D, Alavi A. Evolving Concept of Imaging Bone Marrow Metastasis in the 21st Century: Critical Role of FDG-PET. Eur J Nucl Med Mol Imaging 2008;35:465-71. (Pubitemid 351661671)
3. Basu S, Alavi A. "Bone Marrow" and not "Bone" is the primary site of skeletal metastasis: Critical Role of FDG-PET in this setting. J Clin Oncol 2007;25:1297.
4. Morris MJ, Akhurst T, Larson SM, Ditullio M, Chu E, Siedlecki K, et al. Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy. Clin Cancer Res 2005;11:3210-6. (Pubitemid 40627867)
5. Meirelles GS, Schöder H, Ravizzini GC, Gönen M, Fox JJ, Humm J, et al. Prognostic value of baseline 18F fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer. Clin Cancer Res 2010;16:6093-9.
6. Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 2002;59:913-8. (Pubitemid 34522186)